Preparation and biological characterization of isomeric 188Re(V) oxocomplexes with tetradentate S4 ligands derived from meso-dimercaptosuccinic acid for labeling of biomolecules

Bioconjugate Chemistry

Volumn 17, Issue 6, 2006, Pages 1601-1606

  Seifert, Sepp ^a   Heinrich, Tobias ^a   Jentschel, Christian ^a   Smuda, Christian ^a   Bergmann, Ralf ^a   Pietzsch, Hans Juergen ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOMOLECULES; CROWN ETHERS; HYDROPHILICITY; ISOMERS; RATS; RHENIUM; SYNTHESIS (CHEMICAL);

BIOLOGICAL CHARACTERIZATION; CROWN-ETHERS; DIMERCAPTOSUCCINIC ACIDS; FIVE-COORDINATED; HYDROPHILICS; IN-VIVO; LABELINGS; SYNTHESISED; TETRADENTATE; TUMOR-TARGETING;

LIGANDS;

CROWN ETHER DERIVATIVE; LIGAND; OXORHENIUM DERIVATIVE; OXOTECHNETIUM DERIVATIVE; RADIOISOTOPE; RHENIUM 188; RHENIUM SULFUR DERIVATIVE; SUCCIMER; SULFUR DERIVATIVE; TECHNETIUM 99M; TECHNETIUM DERIVATIVE; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG STABILITY; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHILICITY; IN VIVO STUDY; ISOMERISM; ISOTOPE LABELING; LIGAND BINDING; MALE; MOLECULAR MODEL; NONHUMAN; RAT; REACTION ANALYSIS; STEREOISOMERISM;

RATTUS NORVEGICUS;

EID: 33845189303     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0602331     Document Type: Article

References (16)

1. Knapp, F. F. (1998) Rhenium-188 - a generator-derived radioisotope for cancer therapy. Cancer Biother. Radiopharm. 13, 337-349.
2. Knapp, F. F., Beets, A. L., Guhlke, S., Zamora, P. O., Bender, H., Palmedo, H., and Biersack, H.-J. (1997) Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment. Anticancer Res. 17, 1783-1796.
3. 188Re labeled radiopharmaceuticals: an overview of promising results from initial clinical trials. Cancer Biother. Radiopharm. 5, 707-717.
4. Alberto, R., Schibli, R., Angst, D., Schubiger, P. A., Abram, U., Abram, S., and Kaden, T. A. (1997) Application of technetium and rhenium carbonyl chemistry to nuclear medicine. Trans. Met. Chem. 22, 597-601.
5. + and synthesis of tailor-made bifunctional ligand systems. Bioconjugate Chem. 13, 750-756.
6. -. Nucl. Med. Biol. 30, 381-387.
7. 188Re analogues. Bioconjugate Chem. 15, 856-863.
8. 3/P ('4+1') coordination: relation of structure with antioxidation stability. Bioconjugate Chem. 16, 634-643.
9. 2 core. Inorg. Chem. 20, 1629-1632.
10. Rao, T. N., Adhikesavalu, D., Camerman, A., and Fritzberg, A. R. (1990) Technetium(V) and rhenium(V) complexes of 2, 3-bis-(mercaptoacetamido) propanoate: chelate ring stereochemistry and influence on chemical and biological properties. J. Am. Chem. Soc. 112, 5798-5804.
11. 3 as prosthetic groups for labeling amines and peptides: approaches with pre- and postconjugate labeling. Nucl. Med. Biol. 25, 621-631.
12. Heinrich, T., Kraus, W., Pietzsch, H.-J., Smuda, C., and Spies, H. (2005) A novel rhenium chelate system derived from dimercaptosuccinic acid for the selective labeling of biomolecules. Inorg. Chem. 44, 9930-9937.
13. 99mTc(V) complexes with SH group-containing proteins. Appl. Radiat. Isot. 54, 637-644.
14. Blower, P. J., Lam, A. S. K., O' Doherty, M. J., Kettle, A. G., Coakley, A. J., and Knapp, F. F., Jr. (1998) Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies. Eur. J. Nucl. Med. 25, 613-621.
15. 188Re(V)-meso-2, 3-dimercaptosuccinic acid. Nucl. Med. Biol. 27, 309-314.
16. 188Re complexes under mild conditions. Appl. Radiat. Isot. 64, 223-227.